Market Overview

UPDATE: Goldman Sachs Downgrades CME Group to Sell on EPS Risk

Related CME
Fast Money Picks For September 18 - Metlife Inc, CME Group Inc And More
UPDATE: GFI Issues Response to Unsolicited Bid from BGC, Sees Offer as Reasonably Leading to Superior Proposal, Continues to support Deal with CME
CME Glitch Halts Electronic Trading in Some Commodities (Fox Business)

Goldman Sachs reduced its rating on CME Group (NASDAQ: CME) from Neutral to Sell and reduced its price target from $53 to $48.

Goldman Sachs noted, "Although we view CME as the leading global futures exchange, with resilient margins and a powerful capital deployment strategy, we believe the Street is too optimistic on CME's near-term EPS outlook (we are 8% below consensus for 2013) given the most recent volume and open interest trends. Moreover, following CME's recent variable dividend announcement on 12/5/2012, we expect investor focus could shift back to the firm's core fundamentals, which continue to deteriorate with total open interest down 12% yoy through November."

CME Group closed at $54.96 on Friday.

Latest Ratings for CME

DateFirmActionFromTo
Sep 2014Keefe Bruyette & WoodsMaintainsOutperform
Sep 2014Deutsche Bank
Sep 2014Deutsche BankInitiates Coverage onBuy

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters